Financial Instruments and Fair Value Measurement (Tables)

12 Months Ended

Dec. 31, 2020

Schedule of Financial Assets and Liabilities Accounted for at Fair Value

The following tables show, by level within the fair value hierarchy, the Company’s financial assets and liabilities that are accounted for at fair value on a recurring basis at December 31, 2020 and 2019 (in millions):


Asset (Liability)	Quoted Prices in Active Markets for Identical Assets (Level 1)		Quoted Prices in Active Markets for Similar Assets (Level 2)		Unobservable inputs for which little or no market data exists (Level 3)		Total
Money market funds (a)	$	26.6	$	—	$	—	$	26.6

Available for sale investments	—		57.7		—		57.7
Trading securities	22.7		—		—		22.7
Deferred compensation plan liabilities	(22.7)		—		—		(22.7)
Derivatives:

Forward exchange contracts-(Liabilities) (b)	—		(0.8)		—		(0.8)
BALANCE AT DECEMBER 31, 2020	$	26.6	$	56.9	$	—	$	83.5


Asset (Liability)	Quoted Prices in Active Markets for Identical Assets (Level 1)		Quoted Prices in Active Markets for Similar Assets (Level 2)		Unobservable inputs for which little or no market data exists (Level 3)		Total
Money market funds (a)	$	27.5	$	—	$	—	$	27.5

Available-for-sale investments	—		50.7		—		50.7
Trading securities	19.2		—		—		19.2
Deferred compensation plan liabilities	(19.2)		—		—		(19.2)
Derivatives:

Forward exchange contracts-(Liabilities) (b)	—		(0.3)		—		(0.3)
BALANCE AT DECEMBER 31, 2019	$	27.5	$	50.4	$	—	$	77.9

(a)Money market funds and time deposits are included in Cash and cash equivalents in the Consolidated Balance Sheet.

(b)Forward exchange contracts-(Liabilities) are reflected in Other accrued liabilities in the Consolidated Balance Sheet.